User profiles for Claire J. Steves
 | Claire StevesProfessor of Ageing and Health Verified email at kcl.ac.uk Cited by 25154 |
[HTML][HTML] Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study
Background Data for front-line health-care workers and risk of COVID-19 are limited. We
sought to assess risk of COVID-19 among front-line health-care workers compared with the …
sought to assess risk of COVID-19 among front-line health-care workers compared with the …
[HTML][HTML] Attributes and predictors of long COVID
Reports of long-lasting coronavirus disease 2019 (COVID-19) symptoms, the so-called ‘long
COVID’, are rising but little is known about prevalence, risk factors or whether it is possible …
COVID’, are rising but little is known about prevalence, risk factors or whether it is possible …
[HTML][HTML] Real-time tracking of self-reported symptoms to predict potential COVID-19
A total of 2,618,862 participants reported their potential symptoms of COVID-19 on a
smartphone-based app. Among the 18,401 who had undergone a SARS-CoV-2 test, the proportion …
smartphone-based app. Among the 18,401 who had undergone a SARS-CoV-2 test, the proportion …
[HTML][HTML] Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study
Background The Pfizer-BioNTech (BNT162b2) and the Oxford-AstraZeneca (ChAdOx1
nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase 3 trials. We …
nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase 3 trials. We …
[HTML][HTML] Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based …
Background COVID-19 vaccines show excellent efficacy in clinical trials and effectiveness
in real-world data, but some people still become infected with SARS-CoV-2 after vaccination. …
in real-world data, but some people still become infected with SARS-CoV-2 after vaccination. …
[HTML][HTML] Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance …
Background The SARS-CoV-2 variant of concern, omicron, appears to be less severe than
delta. We aim to quantify the differences in symptom prevalence, risk of hospital admission, …
delta. We aim to quantify the differences in symptom prevalence, risk of hospital admission, …
Large-scale association analyses identify host factors influencing human gut microbiome composition
To study the effect of host genetics on gut microbiome composition, the MiBioGen consortium
curated and analyzed genome-wide genotypes and 16S fecal microbiome data from …
curated and analyzed genome-wide genotypes and 16S fecal microbiome data from …
Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2
The omicron variant of SARS-CoV-2 (PANGO B. 1.1. 529) spread rapidly across the world,
out-competing former variants soon after it was first detected in November, 2021. According to …
out-competing former variants soon after it was first detected in November, 2021. According to …
[HTML][HTML] Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records
…, NJ Timpson, N Chaturvedi, CJ Steves - Nature …, 2022 - nature.com
The frequency of, and risk factors for, long COVID are unclear among community-based
individuals with a history of COVID-19. To elucidate the burden and possible causes of long …
individuals with a history of COVID-19. To elucidate the burden and possible causes of long …
[HTML][HTML] Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2
Background In children, SARS-CoV-2 infection is usually asymptomatic or causes a mild
illness of short duration. Persistent illness has been reported; however, its prevalence and …
illness of short duration. Persistent illness has been reported; however, its prevalence and …